NCT05263141Completed
Retro-Auricular Single-Site Endoscopic to Papillary Thyroid Carcinoma
Single-center, Prospective, Non-Randomized Control Clinical Trial of Retro-Auricular Single-Site Endoscopic Versus Open Surgery in Patients With Early Stage Papillary Thyroid Carcinoma
Source: ClinicalTrials.gov · Last updated 3 Dec 2024
Brief summary (registry, in English)
The goal of this non randomized control clinical research study is to compare the cosmetic outcomes and efficiacy of retro-auricular single-site endoscopic thyroid lobectomy and central lymph node dissection against conventional resection.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 80 (actual)
- First submitted
- 20 Feb 2022
- Start date
- 1 Mar 2022
- Primary completion date
- 30 Nov 2024
- Lead sponsor
- Sun Yat-sen University
- Diseases
- Thyroid cancer
- NCT number
- NCT05263141
What you commit to
- Study type: Interventional
- Participants enrolled: 80
- From 1 Mar 2022 to the primary completion date, 30 Nov 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who have undergone neck surgery or radiotherapy before this trail.
Other
- Patients who do not accept case data collection for various reasons.
- The clinical data unfit this study (at the discretion of the investigator).
- Patients who have uncontrolled hyperthyroidism.
Who the study is looking for
- Age 18-70 years old, no gender restrictions.
- Fine-needle aspiration cytology(FNA) confirmed papillary thyroid carcinoma(PTC).
- Early stage PTC (stage T1N0M0).
- Preoperative ultrasonography showed unilateral glandular lobe malignant tumor and the largest diameter was not more than 2cm, without cervical lymph node metastasis and extensive metastasis.
- Patients undergoing thyroid lobectomy and central lymph node dissection.
- Patients who have signed an approved Informed Consent.
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sun Yat-sen University Cancer Center Coordinator of this site? Confirm its status | Guangzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.